Induction of cystine-glutamate transporter Xc- by human immunodeficiency virus type 1 transactivator protein Tat in retinal pigment epithelium

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 9, 2004, Pages 2906-2914

  Bridges, Christy C ^a   Hu, Huankai ^a   Miyauchi, Seiji ^a   Siddaramappa, Umapathy N ^a   Ganapathy, Malliga E ^a   Ignatowicz, Leszek ^a   Maddox, Dennis M ^a   Smith, Sylvia B ^a   Ganapathy, Vadivel ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CYSTINE GLUTAMATE TRANSPORTER X C; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; MESSENGER RNA; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; NORTHERN BLOTTING; OXIDATIVE STRESS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; VIRUS GENOME; WESTERN BLOTTING;

AMINO ACID TRANSPORT SYSTEM Y+; ANIMALS; ANTIGENS, CD98 HEAVY CHAIN; CELL LINE; GAMMA-GLUTAMYLTRANSFERASE; GENE PRODUCTS, TAT; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; HIV-1; HOMEOSTASIS; HUMANS; ISOENZYMES; KINETICS; MICE; MICE, TRANSGENIC; PIGMENT EPITHELIUM OF EYE; RETINA; RNA, MESSENGER; UP-REGULATION;

EID: 4344601384     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-1355     Document Type: Article

References (53)

1. Palacin M, Estevez R, Bertran J, Zorzano A. Molecular biology of mammalian plasma membrane amino acid transporters. Physiol Rev. 1998;78:969-1054.
2. Ganapathy V, Inoue K, Prasad PD, Ganapathy ME. Cellular uptake of amino acids: system and regulation. In: Cynober LA, ed. Amino Acid Metabolism and Therapy in Health and Nutritional Diseases. 2nd ed. Boca Raton, FL: CRC Press; 2004:63-78.
3. Chillaron J, Roca R, Valencia A, Zorzano A, Palacin M. Heteromeric amino acid transporters: biochemistry, genetics, and physiology. Am J Physiol. 2001;281:F995-F1018.
4. Kanai Y, Endou H. Heterodimeric amino acid transporters: molecular biology and pathological and pharmacological relevance. Curr Drug Metab. 2001;2:339-354.
5. Sato H, Tamba M, Ishii T, Bannai S. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J Biol Chem. 1999;274:11455-11458.
6. -. Antioxid Redox Sign. 2000;2: 665-671.
7. Bridges CC, Kekuda R, Wang H, et al. Structure, function, and regulation of human cystine/glutamate transporter in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2001;42:47-54.
8. -. Pflugers Arch. 2001;442: 286-296.
9. Kim JY, Kanai Y, Chairoungdua A, et al. Human cystine/glutamate transporter: cDNA cloning and upregulation by oxidative stress in glioma cells. Biochim Biophys Acta. 2001;1512:335-344.
10. Sato H, Kuriyama-Matsumura K, Hashimoto T, et al. Effect of oxygen on induction of the cystine transporter by bacterial lipopolysaccharide in mouse peritoneal macrophages. J Biol Chem. 2001;276:10407-10412.
11. Gukasyan HJ, Kannan R, Lee VH, Kim KJ. Regulation of L-cystine transport and intracellular GSH level by a nitric oxide donor in primary cultured rabbit conjunctival epithelial cell layers. Invest Ophthalmol Vis Sci. 2003;44:1202-1210.
12. Hosoya K, Tomi M, Ohtsuki S, et al. Enhancement of L-cystine transport activity and its relation to xCT gene induction at the blood-brain barrier by diethyl maleate treatment. J Pharmacol Exp Ther. 2002;302:225-231.
13. Tomi M, Hosoya K, Takanaga H, Ohtsuki S, Terasaki T. Induction of xCT gene expression and L-cystine transport activity by diethyl maleate at the inner blood-retinal barrier. Invest Ophthalmol Vis Sci. 2002;43:774-779.
14. Sasaki H, Sato H, Kuriyama-Matsumura K, et al. Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J Biol Chem. 2002;277: 44765-44771.
15. Shih AY, Johnson DA, Wong G, et al. Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J Neurosci. 2003; 23:3394-3406.
16. Baker DA, Xi ZX, Shen H, Swanson CJ, Kalivas PW. The origin and neuronal function of in vivo nonsynaptic glutamate. J Neurosci. 2002;22:9134-9141.
17. -, in the mouse brain. J Neurosci. 2002;22:8028-8033.
18. Baker DA, McFarland K, Lake RW, et al. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci. 2002;6:743-749.
19. Chase LA, Roon RJ, Wellman L, Beitz AZ, Koerner JF. L-Quisqualic acid transport into hippocampal neurons by a cystine-sensitive carrier is required for the induction of quisqualate sensitization. Neuroscience. 2001;106:287-301.
20. Droge W. Cysteine and glutathione deficiency in AIDS patients: a rationale for the treatment with N-acetyl-cysteine. Pharmacology. 1993;46:61-65.
21. Staal FJ. Glutathione and HIV infection: reduced, or increased oxidized? Eur J Clin Invest. 1998;28:194-196.
22. Favier A, Sappey C, Leclerc P, Faure P, Micoud M. Antioxidant status and lipid peroxidation in patients infected with HIV. Chem Biol Interact. 1994;91:165-180.
23. Rieder MJ, Krause R, Bird IA, Dekaban GA. Toxicity of sulfonamide-reactive metabolites in HIV-infected, HTLV-infected, and noninfected cells. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:134-140.
24. Mollace V, Nottet HS, Clayette P, et al. Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants. Trends Neurosci. 2001;24:411-416.
25. Palamara AT, Garaci E, Rotilio, G, et al. Inhibition of murine AIDS by reduced glutathione. AIDS Res Hum Retroviruses. 1996;12: 1373-1381.
26. Kameoka M, Okada Y, Tobiume M, Kimura T, Ikuta K. Intracellular glutathione as a possible direct blocker of HIV type 1 reverse transcription. AIDS Res Hum Retroviruses. 1996;12:1635-1638.
27. Eck HP, Stahl-Hennig C, Hunsmann G, Droge W. Metabolic disorder as early consequence of simian immunodeficiency virus infection in rhesus macaques. Lancet. 1991;338:346-347.
28. Garaci E, Palamara AT, Ciriolo MR, et al. Intracellular GSH content and HIV replication in human macrophages. J Leukoc Biol. 1997; 62:54-59.
29. Opalenik SR, Ding Q, Mallery SR, Thompson JA. Glutathione depletion associated with the HIV-1 TAT protein mediates the extracellular appearance of acidic fibroblast growth factor. Arch Biochem Biophys. 1998;351:17-26.
30. Choi J, Liu RM, Kundu RK, et al. Molecular mechanism of decreased glutathione content in human immunodeficiency virus type 1 Tat-transgenic mice. J Biol Chem. 2000;275:3693-3698.
31. Raidel SM, Haase C, Jansen NR, et al. Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage. Am J Physiol. 2002;282:H1672-H1678.
32. Griffith OW, Mulcahy RT. The enzymes of glutathione synthesis: gamma-glutamylcysteine synthetase. Adv Enzymol Rel Areas Mol Biol. 1999;73:209-267.
33. Cai J, Nelson KC, Wu M, Sternberg P Jr, Jones DP. Oxidative damage and protection of the RPE. Prog Retin Eye Res. 2000;19: 205-221.
34. --coupled transport system for endogenous opioid peptides in retinal pigment epithelium and induction of the transport system by HIV-1 Tat. Biochem J. 2003;375:17-22.
35. Ganapathy V, Mendicino J, Leibach FH. Transport of glycyl-L-proline into intestinal and renal brush border vesicles from rabbit. J Biol Chem. 1981;256:118-124.
36. Ganapathy V, Mendicino J, Leibach FH. Evidence for a dipeptide transport system in renal brush border membranes from rabbit. Biochim Biophys Acta. 1981;642:381-391.
37. o,+-like amino acid transporter functioning as a heterodimer with 4F2hc instead of rBAT: a new candidate gene for cystinuria. J Biol Chem. 1999;274:29005-29010.
38. Wu X, Prasad PD, Leibach FH, Ganapathy V. cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun. 1998;246:589-595.
39. Kouskoff V, Fehling H-J, Lemeur M, Benoist C, Mathis D. A vector driving the expression of foreign cDNAs in the MHC class II-positive cells of transgenic mice. J Immunol Methods. 1993;166: 287-291.
40. St. Jules RS, Smith SB, O'Brien PJ. The localization and timing of post-translational modifications of rat rhodopsin. Exp Eye Res. 1990;51:427-434.
41. Meister A. Glutathione metabolism and its selective modification. J Biol Chem. 1988;263:17205-17208.
42. Moore P, El-Sherbeny A, Roon P, Schoenlein PV, Ganapathy V, Smith SB. Apoptotic cell death in the mouse retinal ganglion cell layer is induced in vivo by the excitatory amino acid homocysteine. Exp Eye Res. 2001;73:45-57.
43. Freeman WR. Retinal disease associated with AIDS. Aust N Z J Ophthalmol. 1993;21:71-78.
44. Harkins T. Noninfectious retinopathy. Optom Vis Sci. 1995;72: 302-304.
45. Kuppermann BD. Noncytomegalovirus-related chorio-retinal manifestations of the acquired immunodeficiency syndrome. Semin Ophthalmol. 1995;10:125-141.
46. Hammond RR, Achim CL, Wiley CA. Neuropathology of the retina in acquired immunodeficiency syndrome. Semin Ophthalmol. 1995;10:177-182.
47. Quiceno JI, Capparelli E, Sadun AA, et al. Visual dysfunction without retinitis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1992;113:8-13.
48. Donahue SP. Human immunodeficiency virus-associated vision loss: electroretinogram attenuation. Am J Ophthalmol. 1998;126: 729-731.
49. Sample PA, Plummer DJ, Mueller AJ, et al. Pattern of early visual field loss in HIV-infected patients. Arch Ophthalmol. 1999;117: 755-760.
50. Plummer DJ, Bartsch DU, Azen SP, Max S, Sadun AA, Freeman WR. Retinal nerve fiber layer evaluation in human immunodeficiency virus-positive patients. Am J Ophthalmol. 2001;131:216-222.
51. Bartel P, Roux P, van Niekerk M. Vitamin A status in relation to electroretinographic and electrooculographic findings in HIV infection. Clin Neurophysiol. 2000;111:1234-1240.
52. Jabs DA, Green WR, Fox R, Polk BF, Bartlett JG. Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology. 1989;96:1092-1099.
53. Spalding JM. Central serous chorioretinopathy and HIV. J Am Optom Assoc. 1999;70:391-398.